Asset Management Corp Hepion Pharmaceuticals, Inc. Transaction History

Asset Management Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$1.14 - $1.58 $152,190 - $210,930	-133,500 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$1.39 - $2.1 $58,379 - $88,200	42,000 Added 45.9%	133,500 $204,000
Q2 2021 Aug 06, 2021	BUY	$1.56 - $2.26 $142,740 - $206,789	91,500 New	91,500 $181,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $51.8M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Asset Management Corp , based on Form 13F filings with the SEC.

Stay updated on Asset Management Corp with notifications on news.